A documentary about Bruce Springsteen and the E Street Band reveals his wife and bandmate Patti Scialfa has been living with ...

Superiority of melphalan–prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma.

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

Films like Strong: Living with Multiple Myeloma are essential. Multiple Myeloma is not exactly high on the list of diseases ...

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...

with bortezomib (Velcade), lenalidomide (Revlimid), and limited dexamethasone was safe and effective for older multiple myeloma patients ineligible for autologous hematopoietic stem cell ...

Thalidomide was the first immunomodulatory agent approved for use in myeloma. Although highly ... in maintenance therapies after autologous stem cell transplantation (ASCT) and following frontline ...

Multiple Genetic Abnormalities Lead to Poor Prognosis Around 5900 people are diagnosed with myeloma each year ... chemotherapy, and stem cell transplants. More than half of patients survive ...

Idecabtagene vicleucel induced high complete response and minimal residual disease negativity rates in multiple myeloma after ...

Paris: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in ...

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...